Systemic lupus erythematosus (SLE) is a problem with the immune system. It causes the immune system to make antibodies that attack the body's healthy cells and tissue. There are many forms of lupus, but SLE is the most common.
The cause is unknown.
SLE is more common in women aged 15-45 years old. It is also more common in people who are Black, Asian, and Hispanic.
Other factors that raise your risk are:
Symptoms can be mild or very severe. It can affect one part of the body or many. Though symptoms can be lasting, there are often times without symptoms in between.
You may have:
Your doctor will ask about your symptoms and health history. A physical exam will be done. Symptoms differ for each person and change over time, making it hard to diagnose.
You may have:
SLE can’t be cured. Symptoms can be managed with medicines and lifestyle changes. Talk with your doctor about the best plan for you. It will depend on the severity and location of your symptoms.
There are many medicines that are used, such as:
You may need to take more than one of these medicines.
Some changes can help you prevent flare-ups. Changes to your medicines may also be used to prevent them. Work with your doctor to make a plan. This may mean that you:
SLE is best managed with strong communication between you and your healthcare team. Make sure to go to all appointments as advised. Let your doctor know about any changes in your health or care program.
Depression in people with SLE is common. Surround yourself with supportive family and friends. If you are still having problems, seek counseling or join a support group.
There is no way to prevent SLE since the cause is not known.
Lupus Foundation of America
Lupus Research Institute
The Kidney Foundation of Canada
Handout on health: Systemic lupus erythematosus. National Institute of Arthritis and Musculoskeletal and Skin Diseases website. Available at: http://www.niams.nih.gov/Health_Info/Lupus/default.asp. Updated June 30, 2016. Accessed August 15, 2018.
Systemic lupus erythematosus (SLE). EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T115873/Systemic-lupus-erythematosus-SLE. Updated July 20, 2018. Accessed August 15, 2018.
Understanding lupus. Lupus Foundation of America website. Available at: http://www.lupus.org/answers/topic/understanding-lupus. Accessed August 15, 2018.
12/4/2009 DynaMed Plus Systematic Literature Surveillancehttp://www.dynamed.com/topics/dmp~AN~T115873/Systemic-lupus-erythematosus-SLE: Hartkamp A, Geenen R, Godaert GL, et al. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial. Ann Rheum Dis. 2010;69(6):1144-1147.
5/6/2011 DynaMed Plus Systematic Literature Surveillancehttp://www.dynamed.com/topics/dmp~AN~T115873/Systemic-lupus-erythematosus-SLE: Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060-2068.
11/25/2013 DynaMed Plus Systematic Literature Surveillance.http://www.dynamed.com/topics/dmp~AN~T115873/Systemic-lupus-erythematosus-SLE: Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF. Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol. 2012;39(10):1964-1970.
Last reviewed May 2018 by EBSCO Medical Review Board Daniel A. Ostrovsky, MD Last Updated: 8/15/2018